Adage Capital Partners
TRAW icon

Adage Capital Partners’s Traws Pharma TRAW Stock Holding History

Adage Capital Partners’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$616K Hold
730,000
– – ﹤0.01% 904
2026
Q1 		$1.34M Hold
730,000
– – ﹤0.01% 865
2025
Q4 		$825K Buy
730,000
+400,000
+121% +$890K ﹤0.01% 856
2025
Q3 		$611K Hold
330,000
– – ﹤0.01% 842
2025
Q2 		$488K Hold
330,000
– – ﹤0.01% 809
2025
Q1 		$759K Buy
+330,000
New +$1.72M ﹤0.01% 803

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Adage Capital Partners's TRAW Position: Q2 2026 in Review

Adage Capital Partners held its Traws Pharma (TRAW) position steady in Q2 2026 at 730,000 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

Adage Capital Partners first reported a position in TRAW in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.34M in Q1 2026. 34 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Adage Capital Partners held 730,000 shares of Traws Pharma worth $616K as of Q2 2026.
  • Adage Capital Partners left its Traws Pharma share count unchanged in Q2 2026.
  • Traws Pharma made up ﹤0.01% of Adage Capital Partners's portfolio in Q2 2026, its #904 holding.
  • Adage Capital Partners first reported a position in Traws Pharma in Q1 2025 and has held it in 6 quarters since.
  • Adage Capital Partners's Traws Pharma position peaked at $1.34M in Q1 2026.
  • 34 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.